Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAddition of Revision: v3.4.2 and removal of the generic government funding status notice (and the prior Revision: v3.4.1) appear to be administrative site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedSite-wide notices about government funding and NIH Clinical Center operating status are displayed, and the page version has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedGlossary is now shown, update-history fields (Last Update Submitted that Met QC Criteria and Last Update Posted) are added, No FEAR Act Data is included, and the page revision is shown as v3.4.0.SummaryDifference0.3%

- Check35 days agoChange DetectedThe page now adds Ovarian cancer as a related topic and includes MedlinePlus Genetics in related topics, a minor metadata update that does not affect study details or decisions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4; removed Ovarian cancer and MedlinePlus Genetics, along with Revision: v3.3.3 from the related topics.SummaryDifference0.2%

- Check49 days agoChange DetectedAdded related topics: Ovarian cancer and MedlinePlus Genetics to the page.SummaryDifference0.2%

Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.